Abstract

This scientific paper presents an overview of continuous solution crystallization in the pharmaceutical industry. Since the specific knowledge spectrum of precipitation is very broad, topics covering the following were analyzed and assessed in detail: a comparison between batch and continuous crystallizers, their engineering advantages/disadvantages, the introduction of the solid form structuring to continuously oriented chemical production, and the usage of the online process analytical technology (PAT) methodologies in interacting functional systems. Furthermore, mechanistic multiscale modeling, whose understanding is of decisive importance for further control application development, was thoroughly discussed as well. The multiscale modeling section also includes the simulation of processes and the optimization of crystallizers. In the last section, model-based predictive control (MPC) is considered, which also covers the intensification approach methods in the field of crystal formation and the introduction of new, highly potential continuous systems, e.g. the coiled flow inverter (CFI) crystallizer, in industry and academia. In the mentioned main sections, individual theme-related articles are collected, discussed, and compared; therefore, a reader can get acquainted with pieces of research, their found results, which have been developed until now, and various emerging perspectives. With regard to the importance of crystallization in the pharmaceutical industry, a reader can already find literature on continuous crystallization. However, due to the growing tendency toward the synthesis of products with specific properties which cannot be achieved with conventional approaches, more attention has been paid in the present work to the establishment of continuous systems for the production of specific fine chemicals. In addition, continuous crystallization could also enable more efficient and “on-demand” production, modeling for optimization, MPC, and intensification approaches. A review of the literature classifying studies according to the choice of a continuous system and their description was omitted in this study, as such reviews are already available in the literature.

Highlights

  • Crystallization is a separation process very commonly used in the industry of many different materials, from commercially very common chemicals to very specific ones

  • Comparable crystal size distribution (CSD); Higher supersaturation was needed in the mixed suspension mixed product removal (MSMPR) crystallizer

  • Smaller chord lengths were obtained in the laminar-flow tubular crystallizers (LFTC); Higher chord count was obtained in the LFTC; Polymorphic form of paracetamol was synthesied in the LFTC

Read more

Summary

Introduction

Crystallization is a separation process very commonly used in the industry of many different materials, from commercially very common chemicals to very specific ones. It plays an important role in the pharmaceutical industry, as more than 90% of active pharmaceutical ingredients (API) are synthesized as a crystalline product.[1,2] Crystallization may have a significant direct and indirect influence on the quality of a product; it is one of the most important purification and separation methods in the production of APIs. Batch production is the oldest approach in the crystallization industry and is still the predominant method in the industry today,[2] there are more time and economically efficient types of production known continuous manufacturing. The most commonly used continuous systems in the pharmaceutical industry are mixed suspension mixed product removal (MSMPR) crystallizers and tubular or plug flow crystallizers (PFC): laminar-flow tubular crystallizers (LFTC), coiled flow inverter (CFI) crystallizers, segmented/slug flow crystallizers, and continuous oscillatory baffled crystallizers (COBC)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call